Menu Close

Inaugural Investigator Briefing


Restoret™ (EYE103)

Inaugural Investigator Briefing 

The EyeBio team is delighted to invite you to the Inaugural Restoret™ Investigator Briefing. We are bringing together our selected investigators for an exclusive, first-time discussion of our first asset, Restoret™, and review of the associated AMARONE clinical trial.

Virtual Meeting 1: Thursday, February 23 at 20:30-21:30  EST | 02:30-03:30  CET

Virtual Meeting 2: Friday, February 24 at 12:00-13:00 EST | 18:00-19:00 CET 

EyeBio thanks you and your teams for being a part of the Restoret™ program. 

We look forward to telling you more about EyeBio next month and to working with you on the AMARONE trial. 

David Guyer, MD (CEO), Tony Adamis, MD (CSO) and Jon Prenner, MD (CMO)

Contact: for any queries relating to attending the events.


Please select a valid form